abstract |
In one aspect, the invention provides a method of reducing proteinuria in a human subject suffering from, or at risk of developing, immunoglobulin A nephropathy (IgAN). The method comprises administering to a subject in need thereof an amount of a MASP-2 inhibiting antibody effective to inhibit MASP-2-dependent complement activation. |